FRNM · Freenome
AI read · Good for FRNM
The AI's read
FDA approval let Freenome count $180.0 million from a collaboration and license deal as sales, and it ended the quarter with $430.0 million in cash and investments. But that deal supplied nearly all quarterly sales. The full-year forecast also counts research services and early sales, so the report does not yet show steady demand for the test.